Beta1 and Beta3 Integrins in Prostate Cancer
Abstract
The study of the molecular mechanisms that control cell growth and motility in prostate cancer is an under-investigated area of research, whereas significant progress has recently been made in breast cancer in this field. Members of the Integrin family of cell adhesion receptors, have emerged as crucial regulators of proliferation, migration, intracellular signaling and gene induction The objective of this study was to investigate the effect of target molecules: beta 1 and beta 3 integrins and their downstream signaling pathways on prostate cancer growth and motility. The proposal has highlighted a new approach to the understanding and control of prostate cancer growth and metastatic lesions. Indeed, the PI has been the first to describe a role for beta 1C integrins in prostate cancer cell proliferation and for beta 3 integrins in prostate cancer cell migration. This study has, thus, allowed new target validation in prostate cancer therapy, thus, meeting the goals of the USAMRMC Prostate Cancer Research Program (PCRP).
Document Details
- Document Type
- Technical Report
- Publication Date
- Jan 01, 2003
- Accession Number
- ADA414864
Entities
People
- Lucia R. Languino
Organizations
- Yale University